{
    "nctId": "NCT02592083",
    "briefTitle": "Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors",
    "officialTitle": "PREDIX Luminal A - Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Early-Stage Breast Carcinoma, Hormone Receptor Positive Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Clinical and Radiological Response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Written informed consent\n2. Female patients with non-lobular breast cancer confirmed by histology\n3. Tumor and blood samples available. Luminal A type confirmed by immunohistochemistry with ER and PR positive \u226550% and the proliferation marker Ki 67 \\<20% and not HER2 amplified\n4. Age older than 40 years\n5. Primary breast cancer \\>20mm without lymph node metastases\n6. Adequate bone marrow, renal, hepatic and cardiac functions and no other uncontrolled medical or psychiatric disorders\n7. LVEF \\>50%\n8. ECOG performance status 0-1\n\nExclusion Criteria:\n\n1. Metastases, including node metastases in the ipsilateral and/or contralateral thoracic region or in the mediastinum\n2. Other malignancy diagnosed within the last five years, except for radically treated basal or squamous cell carcinoma of the skin or CIS of the cervix\n3. Age \u226440 years\n4. Lobular carcinoma\n5. Patients in child-bearing age without adequate contraception\n6. Pregnancy or lactation\n7. Severe medical or psychiatric disorders where the study treatment or study procedures carry increased risk of deterioration of health status",
    "sex": "FEMALE",
    "minimumAge": "41 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}